Does the addition of a biomarker score (NT-proBNP, CRP, and sensitive troponin I) to a conventional risk model improve 10-year risk estimation for cardiovascular events in middle-aged European populations?
Adding a biomarker score of NT-proBNP, CRP, and sensitive troponin I to conventional risk models improves 10-year cardiovascular risk prediction in middle-aged European populations.
The addition of a biomarker score including N-terminal pro-brain natriuretic peptide, C-reactive protein, and sensitive troponin I to a conventional risk model improved 10-year risk estimation for cardiovascular events in 2 middle-aged European populations. Further validation is needed in other populations and age groups.
Blankenberg et al. (Tue,) studied this question.